Major pancreatic cancer breakthrough in decades spurs industry dealmaking frenzy
A significant advance in pancreatic cancer treatment, described as one of the biggest in decades, has sparked a wave of dealmaking among pharmaceutical companies, according to Bloomberg.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Hubs
Briefings
More story pages
Replimune shares surge after US FDA agrees to reconsider skin cancer treatment rejected twice.
Replimune shares rose sharply after the US Food and Drug Administration agreed to reconsider the company's skin cancer treatment, which had previously been rejected twice.
Greenland mental distress rate jumps from 7% to 31% as Trump threats fuel crisis, study finds.
According to a study by a Greenland public health institute, the share of Greenlanders experiencing mental distress rose from 7% to 31% over the past year. The authors attribute the increase to the crisis caused by Trump's threats to seize the island.
UN health chief in DRC to battle Ebola meets authorities Friday, plans to visit violence-hit epicenter Saturday.
The UN health chief, in the Democratic Republic of Congo to help fight an Ebola outbreak, is set to meet Congolese authorities on Friday before heading Saturday to the violence-hit region at the center of the crisis.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.